Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020	2019
Market Capitalization	9,179	5,597	3,419	502	-
Market Cap Growth	-	63.72%	580.90%	-	-
Enterprise Value	3,014	4,402	1,642	-1,386	-2,005
PE Ratio	2.18	-5.55	-4.04	-0.62	-
PS Ratio	74.48	91.34	61.84	21.10	-
PB Ratio	1.51	4.83	2.06	0.28	-
P/FCF Ratio	-10.77	-6.54	-4.92	-0.90	-
P/OCF Ratio	-10.80	-6.64	-5.04	-0.91	-
EV/Sales Ratio	24.46	71.83	29.71	-58.23	-29.61
EV/EBITDA Ratio	0.66	-4.64	-1.99	1.72	-1.66
EV/EBIT Ratio	0.66	-4.51	-1.96	1.72	-1.66
EV/FCF Ratio	-3.42	-5.14	-2.36	2.48	2.62
Debt / Equity Ratio	0.08	0.42	0.17	0.14	0.09
Debt / EBITDA Ratio	0.11	-0.51	-0.34	-0.30	0.15
Debt / FCF Ratio	-0.60	-0.56	-0.41	-0.44	-0.24
Quick Ratio	27.24	6.15	11.18	9.74	23.72
Current Ratio	27.79	6.60	11.64	9.99	24.09
Asset Turnover	0.04	0.03	0.02	0.01	-
Interest Coverage	81.87	-34.89	-119.00	-	-
Return on Equity (ROE)	196.20%	-86.60%	-46.40%	-42.30%	-
Return on Assets (ROA)	128.50%	-42.90%	-30.90%	-31.90%	-
Return on Capital (ROIC)	64.40%	-71.70%	-69.64%	-52.42%	-23.92%
Earnings Yield	48.66%	-18.03%	-24.72%	-161.17%	-
FCF Yield	-9.14%	-15.29%	-20.33%	-111.12%	-
Buyback Yield / Dilution	-18.38%	-6.43%	-6.30%	-187.64%	-
Total Shareholder Return	-18.38%	-6.43%	-6.30%	-187.64%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).